TY - CHAP M1 - Book, Section TI - Perinatal Stroke A1 - Craig, Alexa A1 - Ferriero, Donna M. A2 - Stevenson, David K. A2 - Cohen, Ronald S. A2 - Sunshine, Philip PY - 2015 T2 - Neonatology: Clinical Practice and Procedures AB - Neonatal stroke is estimated to occur in 1 per 2300 to 5000 live births.1 This estimate may be an underrepresentation of the true incidence of neonatal stroke because of the inherent challenges in diagnosing this condition. In the adult, stroke is defined as “rapidly developed signs of focal (or global) disturbance of cerebral function lasting greater than 24 hours (unless interrupted by surgery or death), with no apparent nonvascular cause.”2 In this definition, there is heavy reliance on the clinical signs of neurological dysfunction. These signs are not usually apparent in the neonate because motor dysfunction is not easily appreciated, and sophisticated repertoires of behaviors such as language or the ability to follow commands have not yet developed. In the newborn, symptoms are vague, including encephalopathy, seizures, hypotonia, poor feeding, and apnea. This list of symptoms may be present in many of the diseases treated in the neonatal intensive care unit; therefore, trying to ascertain which are caused by stroke can be immensely challenging. The correct identification of stroke, however, is paramount for many reasons, ranging from identifying potentially modifiable risk factors to acute therapeutic intervention (particularly for sinus venous thrombosis). Managing long-term outcomes, which tend to be poor, is difficult but may improve with aggressive early intervention and emerging therapies such as transcranial magnetic stimulation and constraint-induced therapy. SN - PB - McGraw-Hill Education CY - New York, NY Y2 - 2024/04/19 UR - accesspediatrics.mhmedical.com/content.aspx?aid=1109792065 ER -